Titan Securities Limited has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The audited standalone and consolidated financial results, along with unmodified auditor’s reports, have been finalized. The audit confirmed compliance with accepted accounting standards, ensuring accurate reflection of profit and financial position. Consolidated results include contributions from associates Peptech Biosciences Limited and Titan Biotech Limited, reporting a share of net profit after tax of Rs. 934.11 lakh. The audit found no material misstatements, and the company continues as a going concern, supporting confidence in its financial health.